相关实验视频
Updated: Jan 29, 2026

07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
827
抗脂综合征 (APS) 中的肺栓塞 - 我们在哪里,我们要去哪里?
Mateusz Lucki1, Bogna Grygiel-Górniak2, Ewa Lucka3
1Department and Clinic of Cardiology, University of Medical Sciences, 60-545 Poznań, Poland.
International journal of molecular sciences
|January 28, 2026
概括
肺栓塞 (PE) 是抗脂综合征 (APS) 的严重并发症. 管理重点是长期抗凝药,新兴的策略针对免疫血栓形成机制.
科学领域:
- 心血管医学 心血管医学
- 类风湿病学 类风湿病学
- 血液学 血液学 血液学
背景情况:
- 抗脂综合征 (APS) 是一种自身免疫性疾病,其特征是血栓事件和抗脂抗体 (aPLA).
- 肺栓塞 (PE) 是APS的一个显著并发症,影响11-20%的患者,并且经常作为初始表现.
- 三重阳性aPLA形状与PE复发和慢性血栓栓塞性肺高血压 (CTEPH) 的风险增加有关.
研究的目的:
- 审查目前关于APS中PE流行病学,病理生理学,诊断和管理的证据.
- 在APS中突出涉及PE发展的关键免疫血栓机制.
- 讨论APS中PE风险分层和向治疗的未来方向.
主要方法:
- 在APS中对PE的当前科学文献的综述.
- 流行病学数据和风险因素的总结.
- 分析病理生理机制,诊断方法和治疗策略.
主要成果:
- 勃起前列腺症是APS的主要并发症,特别是在三重阳性aPLA的年轻到中年女性中.
- 免疫血栓形成的机制包括抗β2-葡萄糖蛋白I激活,补充和中性粒细胞外细胞陷.
- 标准的PE诊断算法适用,但对D-二聚体和aPTT的解释需要对APS进行特定考虑.
- 长期的维生素K对抗剂是标准的;对于高风险的APS,不建议使用直接口服抗凝剂.
- 早期CTEPH查和新疗法 (补充抑制,抗NETosis) 是未来的方向.
结论:
- 在APS的PE需要仔细的诊断和管理,考虑到特定的免疫血栓机制.
- 长期抗凝药非常重要,目前正在研究针对高风险患者的向治疗方法.
- 改善风险分层和早期CTEPH检测对于更好的患者结果至关重要.
更多相关视频
相关概念视频
Pulmonary Embolism I: Introduction
672
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
672
Pulmonary Embolism III: Nursing Management
427
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
427
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
393
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
393
Nephrotic Syndrome I : Introduction
609
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
609
Pulmonary Tuberculosis I
923
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
923
Pulmonary Tuberculosis II
1.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K

